Lucy Lu

Board Member, Life Science Angels

Lucy is a Board Member for Life Science Angels. Before this, she was Senior Vice President of Toft Group, an executive search firm that focuses on C-level executive recruitment across all sectors of the Life Sciences industry. Lucy has more than 30 years of biotech industry experiences ranging from developing therapeutics and diagnostics to research tools.  She was most recently the Chief Commercial Officer for iNDx Lifecare Inc. – a point-of-care Dx device startup.  From 2008 to 2014, she served as Senior Vice President of Corporate and Business Development at Crescendo Bioscience Inc.  During her six years at Crescendo, she helped raised $90M in venture funding, supported the development and commercialization of a novel rheumatoid arthritis test and the company was acquired by Myriad Genetics for $270M in early 2014.

Prior to joining Crescendo, she was Vice President, Technology Management and Head of the U.S. Chief Technology Office for Roche Diagnostics for five years, where she built a global team focusing on life sciences, diabetes care, centralized and molecular diagnostics technology scouting and assessment to support corporate strategic planning and M&A.  Lucy had also held various Life Sciences marketing and product development positions at Roche Applied Sciences and PE Applied Biosystems (now Thermo Fisher Scientific).  In her early career, she devoted 10 years in drug R&D at Genentech (now Roche) and Bristol-Myers Squibb.

Lucy is currently a board member of Life Science Angels and also serves as the chair of its member education program to provide LSA members with deep angel investment knowledge to build their successful investment portfolios.  

Education

Lucy holds a BS degree in Botany from National Taiwan University in Taiwan, an MS degree in Plant Biology from University of Illinois at Urbana-Champaign and an MBA from St. Mary’s College at Moraga, California.